134 related articles for article (PubMed ID: 3012947)
1. Effects of the methylxanthine derivative pentoxifylline on benzodiazepine and muscarinic binding sites in rat cerebral cortex.
Lowenstein PR; Aguilar JS; Sabato UC
Acta Physiol Pharmacol Latinoam; 1985; 35(4):431-9. PubMed ID: 3012947
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
Vickroy TW; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
[TBL] [Abstract][Full Text] [Related]
3. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
4. Quantitative autoradiography of muscarinic and benzodiazepine receptors in the forebrain of the turtle, Pseudemys scripta.
Schlegel JR; Kriegstein AR
J Comp Neurol; 1987 Nov; 265(4):521-9. PubMed ID: 2828438
[TBL] [Abstract][Full Text] [Related]
5. Soman- or kainic acid-induced convulsions decrease muscarinic receptors but not benzodiazepine receptors.
Churchill L; Pazdernik TL; Cross RS; Nelson SR; Samson FE
Neurotoxicology; 1990; 11(1):57-71. PubMed ID: 2165227
[TBL] [Abstract][Full Text] [Related]
6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
7. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
8. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
9. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
10. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
11. Altered GABA(A)-benzodiazepine receptor number and pharmacology in the adult guinea pig cerebral cortex after chronic prenatal ethanol exposure.
Bailey CD; Brien JF; Reynolds JN
Alcohol Clin Exp Res; 1999 Nov; 23(11):1816-24. PubMed ID: 10591599
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
Zimmerman TW; Binder HJ
Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
[TBL] [Abstract][Full Text] [Related]
13. Laudanosine does not displace receptor-specific ligands from the benzodiazepinergic or muscarinic receptors.
Katz Y; Gavish M
Anesthesiology; 1989 Jan; 70(1):109-11. PubMed ID: 2536252
[TBL] [Abstract][Full Text] [Related]
14. Discrepancy between cell injury and benzodiazepine receptor binding after transient middle cerebral artery occlusion in rats.
Abe K; Kashiwagi Y; Tokumura M; Hosoi R; Hatazawa J; Inoue O
Synapse; 2004 Sep; 53(4):234-9. PubMed ID: 15266555
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
Aguilar JS; Salas PJ; De Robertis E
Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
[No Abstract] [Full Text] [Related]
16. [Properties of benzodiazepine receptors of the cerebral cortex of rats with various degrees of ethanol preference].
Shushpanova TV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):122-4. PubMed ID: 2543165
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors.
Ward TR; Ferris DJ; Tilson HA; Mundy WR
Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
19. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
Martin MW; Smith MM; Harden TK
J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
[TBL] [Abstract][Full Text] [Related]
20. Effect of pentoxifylline on alpha- and beta-adrenoceptor sites in cerebral cortex medial basal hypothalamus and pineal gland of the rat.
Lowenstein PR; Vacas MI; Cardinali DP
Neuropharmacology; 1982 Mar; 21(3):243-8. PubMed ID: 6280095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
